Combination Olanzapine and Samidorphan for the Management of Schizophrenia and Bipolar 1 Disorder in Adults: A Narrative Review
Schizophrenia is a debilitating psychotic disorder characterized by positive symptoms such as delusions, hallucinations, and disorganized thoughts, and negative symptoms like lack of effect or motivation. Bipolar 1 disorder (B1D) is a psychiatric illness characterized by recurrent manic episodes in...
Saved in:
Main Authors: | Hannah W. Haddad, Elena Boardman, Brooke Williams, Rama Mouhaffel, Adam M. Kaye, Alan D. Kaye |
---|---|
Format: | Article |
Language: | English |
Published: |
Open Medical Publishing
2022-04-01
|
Series: | Health Psychology Research |
Online Access: | https://doi.org/10.52965/001c.34224 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Classification of schizophrenia, bipolar disorder and major depressive disorder with comorbid traits and deep learning algorithms
by: Xiangning Chen, et al.
Published: (2025-02-01) -
Historical Pathways for Opioid Addiction, Withdrawal with Traditional and Alternative Treatment Options with Ketamine, Cannabinoids, and Noribogaine: A Narrative Review
by: Amber N. Edinoff, et al.
Published: (2022-10-01) -
Delusions of Glass Under Skin: An Unusual Case of Somatic-Type Delusional Disorder Treated with Olanzapine
by: Nicholas Comardelle, et al.
Published: (2022-05-01) -
Viloxazine, a Non-stimulant Norepinephrine Reuptake Inhibitor, for the Treatment of Attention Deficit Hyperactivity Disorder: A 3 Year Update
by: Hannah W Haddad, et al.
Published: (2022-07-01) -
Lumateperone tosylate, A Selective and Concurrent Modulator of Serotonin, Dopamine, and Glutamate, in the Treatment of Schizophrenia
by: Kunal Maini, et al.
Published: (2021-06-01)